Detalhe da pesquisa
1.
Stopping versus continuing long-term mepolizumab treatment in severe eosinophilic asthma (COMET study).
Eur Respir J
; 59(1)2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34172470
2.
Efficacy and safety of mepolizumab in hypereosinophilic syndrome: A phase III, randomized, placebo-controlled trial.
J Allergy Clin Immunol
; 146(6): 1397-1405, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32956756
3.
Long-term Safety and Clinical Benefit of Mepolizumab in Patients With the Most Severe Eosinophilic Asthma: The COSMEX Study.
Clin Ther
; 41(10): 2041-2056.e5, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31447130
4.
Long-term Efficacy and Safety of Mepolizumab in Patients With Severe Eosinophilic Asthma: A Multi-center, Open-label, Phase IIIb Study.
Clin Ther
; 38(9): 2058-2070.e1, 2016 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-27553751